BC Innovations | Feb 18, 2016
Distillery Therapeutics

Therapeutics: Potassium channel K2p9.1 (KCNK9)

Cancer INDICATION: Cancer Patient sample, cell culture and mouse studies suggest inhibiting KCNK9 could help treat cancer. In patients with squamous cell lung cancer or breast cancer, low tumor levels of KCNK9 were associated with...
Items per page:
1 - 1 of 1